Hyaluronic Acid

Dr. Sarah Chen
PhD, Molecular Biology
Hyaluronic acid is a non-sulfated, unbranched glycosaminoglycan with a molecular weight that can exceed 1,000 kDa in its native high-molecular-weight form.
Hyaluronic acid (HA), also known as hyaluronan, is a high-molecular-weight glycosaminoglycan (GAG) composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine. It is a major component of the extracellular matrix in connective tissues throughout the body, with particularly high concentrations in the skin, synovial fluid, and vitreous humor of the eye .
Definition
Hyaluronic acid is a non-sulfated, unbranched glycosaminoglycan with a molecular weight that can exceed 1,000 kDa in its native high-molecular-weight form. Unlike other GAGs, HA is not covalently attached to a core protein and is synthesized at the cell membrane by hyaluronan synthases (HAS1, HAS2, HAS3) rather than in the Golgi apparatus . Its most remarkable property is its extraordinary capacity to bind water β a single HA molecule can hold up to 1,000 times its weight in water, making it the most hygroscopic molecule in the human body.
Biochemistry and Structure
Molecular Architecture
HA is a linear polymer that can reach lengths of 2-25 micrometers, with molecular weights ranging from a few kilodaltons (low-molecular-weight HA) to several million daltons (high-molecular-weight HA). In aqueous solution, HA adopts an expanded random coil conformation that occupies a very large hydrodynamic volume relative to its mass. This creates a viscous, gel-like matrix that provides structural support, hydration, and mechanical cushioning .
Turnover and Degradation
The skin contains approximately 50% of all HA in the body. Dermal HA has a half-life of approximately 24 hours, requiring continuous synthesis by fibroblasts to maintain tissue levels. HA is degraded by hyaluronidases and reactive oxygen species, with the resulting fragments exhibiting biological activities distinct from those of the intact high-molecular-weight polymer .
Role in Skin
Hydration
HA is the primary molecule responsible for maintaining skin hydration. Its water-binding capacity creates a hydrated gel within the dermal extracellular matrix that keeps skin plump, supple, and resilient. Age-related decline in HA content is a major contributor to the loss of skin moisture, volume, and elasticity observed with aging .
Extracellular Matrix Organization
HA serves as a scaffold within the extracellular matrix, organizing collagen fibers and other matrix components. It interacts with HA-binding proteins (hyaladherins) such as CD44 and RHAMM to create a structured microenvironment that regulates cell behavior, including fibroblast proliferation, migration, and collagen synthesis .
Wound Healing
HA plays multiple roles in wound healing. High-molecular-weight HA is anti-inflammatory and promotes organized tissue repair, while low-molecular-weight HA fragments stimulate angiogenesis and immune cell recruitment. Fetal wounds, which heal without scarring, contain notably higher levels of HA than adult wounds .
Signaling Functions
Beyond its structural role, HA acts as a signaling molecule. Through interactions with cell surface receptors (particularly CD44 and RHAMM), HA regulates cell proliferation, migration, and differentiation. The biological effects of HA are size-dependent: high-molecular-weight HA is generally anti-inflammatory and anti-angiogenic, while low-molecular-weight fragments are pro-inflammatory and pro-angiogenic .
PDRN Connection
PDRN (polydeoxyribonucleotide) and hyaluronic acid exert complementary and synergistic effects in skin regeneration, making their combination a powerful approach in regenerative skincare .
Complementary Mechanisms
While HA provides immediate hydration and structural support to the extracellular matrix, PDRN works at the cellular level to stimulate the biological processes that produce and maintain the matrix itself. PDRN activates fibroblasts β the cells responsible for synthesizing HA, collagen, and other matrix components β thereby supporting long-term matrix renewal .
Fibroblast Stimulation
PDRN's activation of fibroblasts through the adenosine A2A receptor promotes increased production of extracellular matrix components, including HA itself. This means PDRN does not merely complement externally applied HA but actively stimulates the skin's own HA production, creating a sustained hydration effect that persists beyond the presence of topically applied HA .
Enhanced Tissue Environment
The hydrated matrix created by HA provides an optimal environment for PDRN's cellular effects. Well-hydrated tissue supports better cell-to-cell communication, improved diffusion of signaling molecules, and enhanced nutrient delivery β all of which amplify PDRN's regenerative activity .
Clinical Significance
Skincare Formulations
The combination of HA and PDRN in skincare products β such as the Anua PDRN + Hyaluronic Acid Serum β leverages the synergy between immediate hydration (HA) and cellular regeneration (PDRN). This dual approach addresses both the symptoms and root causes of skin aging and damage.
Dermal Fillers and Biorevitalization
In aesthetic medicine, HA-based dermal fillers are frequently combined with PDRN or polynucleotide treatments. HA provides immediate volume and hydration, while PDRN stimulates endogenous tissue regeneration for longer-lasting improvement .
Age-Related HA Decline
Skin HA content decreases significantly with age β by age 70, dermal HA content may be reduced by approximately 75% compared to young skin. PDRN's ability to stimulate fibroblast activity and matrix production helps counteract this decline by promoting the skin's own HA synthesis .
Related Concepts
- Extracellular Matrix β The tissue structure where HA resides
- Fibroblast β The primary cell type that synthesizes HA in the dermis
- Collagen Synthesis β Another matrix process supported by both HA and PDRN
- Polydeoxyribonucleotide β PDRN's synergistic mechanism with HA
References
- [1]Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: A key molecule in skin aging. Dermatoendocrinol. 2012;4(3):253-258. doi:10.4161/derm.21923
- [2]Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 2006;85(8):699-715. doi:10.1016/j.ejcb.2006.05.009
- [3]Cowman MK, Schmidt TA, Raghavan P, Stecco A. Viscoelastic Properties of Hyaluronan in Physiological Conditions. F1000Res. 2015;4:622. doi:10.12688/f1000research.6912.1
- [4]Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
- [5]Colangelo MT, Galli C, Giannelli M. Polydeoxyribonucleotide: A Promising Biological Platform for Dermal Regeneration. Curr Pharm Des. 2020;26(17):2049-2056.
- [6]Fallacara A, Baldini E, Manfredini S, Vertuani S. Hyaluronic Acid in the Third Millennium. Polymers (Basel). 2018;10(7):701. doi:10.3390/polym10070701